Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei
Léonor Benhaïm(Institut Gustave Roussy), Diane Goèré(Assistance Publique – Hôpitaux de Paris), Matthieu Faron(Institut Gustave Roussy), Maximiliano Gelli(Université Paris-Saclay), Jean‐Baptiste Delhorme(Hôpitaux Universitaires de Strasbourg), Isabelle Sourrouille(Institut Gustave Roussy), Charles Honoré(Institut Gustave Roussy), Dominique Élias(Institut Gustave Roussy)
Cited by 59
Related Papers
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial
|The Lancet. Gastroenterology & hepatology|2020|602
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2020|482
Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma
|British journal of surgery|2017|255